Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (651-660 of 826) with videos related to

Pageof 83
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2026
"Real-world prognostic performance of different severe and advanced heart failure definitions: data from the Swedish Heart Failure Registry"Federica Guidetti, Lars H Lund, Lina Benson, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
European Journal of Heart Failure|January 27, 2009
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fractionErwan Donal, Lars H Lund, Cecilia Linde, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 17, 2024
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes RegistriesMarkus Wallner, Mattia Emanuele Biber, Davide Stolfo, et al.
European Journal of Heart Failure|October 10, 2017
Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term RegistryAlexandre Mebazaa, Justina Motiejunaite, Etienne Gayat, et al.
Plos One|November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor diseaseMarianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
Diabetologia|April 26, 2014
Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathyAmber A W A van der Heijden, Iris Walraven, Esther van 't Riet, et al.
International Journal of Cardiology|May 4, 2020
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial designGianluigi Savarese, Camilla Settergren, Benedikt Schrage, et al.
European Journal of Heart Failure|January 27, 2022
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Marija Polovina, Giuseppe Rosano, et al.
Cell|December 25, 2007
RNA-binding protein Dnd1 inhibits microRNA access to target mRNAMartijn Kedde, Markus J Strasser, Bijan Boldajipour, et al.
Pageof 83

Showing results (651-660 of 826) with videos related to

Sort By:
Pageof 83
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2026
"Real-world prognostic performance of different severe and advanced heart failure definitions: data from the Swedish Heart Failure Registry"Federica Guidetti, Lars H Lund, Lina Benson, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
European Journal of Heart Failure|January 27, 2009
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fractionErwan Donal, Lars H Lund, Cecilia Linde, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 17, 2024
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes RegistriesMarkus Wallner, Mattia Emanuele Biber, Davide Stolfo, et al.
European Journal of Heart Failure|October 10, 2017
Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term RegistryAlexandre Mebazaa, Justina Motiejunaite, Etienne Gayat, et al.
Plos One|November 2, 2018
Dietary intake is associated with risk of multiple myeloma and its precursor diseaseMarianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
Diabetologia|April 26, 2014
Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathyAmber A W A van der Heijden, Iris Walraven, Esther van 't Riet, et al.
International Journal of Cardiology|May 4, 2020
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial designGianluigi Savarese, Camilla Settergren, Benedikt Schrage, et al.
European Journal of Heart Failure|January 27, 2022
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Marija Polovina, Giuseppe Rosano, et al.
Cell|December 25, 2007
RNA-binding protein Dnd1 inhibits microRNA access to target mRNAMartijn Kedde, Markus J Strasser, Bijan Boldajipour, et al.
Pageof 83